about
Perfringolysin O: The Underrated Clostridium perfringens Toxin?Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritisNon-toxic perfringolysin O and α-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis.The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.A new predilection site of Mycoplasma bovis: Postsurgical seromas in beef cattle.Non-haemolytic Mannheimia haemolytica as a cause of pleuropneumonia and septicemia in a calf.Veal Calves Produce Less Antibodies against C. Perfringens Alpha Toxin Compared to Beef CalvesClostridium perfringens strains from bovine enterotoxemia cases are not superior in in vitro production of alpha toxin, perfringolysin O and proteolytic enzymes.Prediction of respiratory disease and diarrhea in veal calves based on immunoglobulin levels and the serostatus for respiratory pathogens measured at arrival.lesion development in a new intestinal loop model indicates the involvement of a shared Clostridium perfringens virulence factor in haemorrhagic enteritis in calves.The synergistic necrohemorrhagic action of Clostridium perfringens perfringolysin and alpha toxin in the bovine intestine and against bovine endothelial cells.Prevalence and bacterial colonisation of fundic ulcerations in veal calves.Intestinal clostridial counts have no diagnostic value in the diagnosis of enterotoxaemia in veal calves.Effect of sedation on the intrapulmonary position of a bronchoalveolar lavage catheter in calves.
P50
Q35662926-45FD830C-4166-4964-9BC7-AD59CE0E482BQ36051245-98500356-ED1F-4371-A7D0-1427B448CC96Q40465195-644D8811-73A1-417A-8B22-E91DA33FCEA6Q40693383-D266DCCA-2067-47F7-B8FA-B694C18B3904Q40739771-6F98B865-9AA3-46A4-A52B-9B6481C189B4Q41013153-0081556F-3D16-4F4D-BE28-95E420C55030Q41577808-61D2771E-2A64-4006-8E43-6F429E9BCCB2Q41914226-E833C29B-76D2-4B70-882C-F9FDE9CE5D8BQ42144481-F7270D73-1FCF-4B20-9192-110AEC88D44BQ42277502-63D8FBBD-4EDF-4C27-83B3-6E5FD257C5CDQ43076582-BF9F95F1-26B9-4935-88B6-126A027FAB05Q43605425-9F4F72B4-D70C-4D4E-902A-23DD94B3F375Q45284489-19C8196D-25FA-4BBB-9151-0D94E2C26C6EQ49053933-E6D99E04-ED0B-491D-A9AD-FE63E4F4835F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bonnie Valgaeren
@ast
Bonnie Valgaeren
@en
Bonnie Valgaeren
@es
Bonnie Valgaeren
@nl
Bonnie Valgaeren
@sl
type
label
Bonnie Valgaeren
@ast
Bonnie Valgaeren
@en
Bonnie Valgaeren
@es
Bonnie Valgaeren
@nl
Bonnie Valgaeren
@sl
prefLabel
Bonnie Valgaeren
@ast
Bonnie Valgaeren
@en
Bonnie Valgaeren
@es
Bonnie Valgaeren
@nl
Bonnie Valgaeren
@sl
P106
P31
P496
0000-0002-9179-4242